NCT06089161Recruiting
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 330 (estimated)
- First submitted
- 12 Oct 2023
- Start date
- 19 Mar 2024
- Primary completion date
- 30 Nov 2027
- Lead sponsor
- University of Miami
- Diseases
- Alzheimer disease
- NCT number
- NCT06089161
What you commit to
- Study type: Interventional
- Planned participants: 330
- From 19 Mar 2024 to the primary completion date, 30 Nov 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- progressive illnesses in which disability or death is expected within 1 year
Other
- impaired cognitive/ functional ability precluding participation
- intention to move within the year
- and a family member currently enrolled.
Who the study is looking for
- Self-reported race/ethnicity as African American, African, Afro-latino, Caribbean or black
- Ages 55-85 years
- accessible by phone
- OSA diagnosis
- consent, including permission to release medical data
Age in the registry: 55 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Miami Coordinator of this site? Confirm its status | Miami | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.